Silymarin treatment of viral hepatitis
The −670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C
Viral evolution of hepatitis C in injection drug users
Identification of glycosaminoglycan-binding sites within hepatitis C virus envelope glycoprotein E2 *
Viral load change and sequential evolution of entire hepatitis C virus genome in Irish recipients of single source-contaminated anti-D immunoglobulin*
Immune tolerance to hepatitis C virus acquired during engraftment of bone marrow transplant
Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China
Pathways of care and resource utilization in a national cohort of patients with transfusion-acquired hepatitis C
Role of nucleic acid testing in cadaver organ donor screening
Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma
Hepatitis B surface antigenaemia and alpha-foetoprotein detection from dried blood spots
Antimitochondrial antibodies in patients with chronic hepatitis C virus infection
Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow
Corrigendum